Arthritis, Rheumatoid: all 2,962 studies

Page 12 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid ArthritisCompletedNCT00424346Phase 2Results posted
• A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid ArthritisTerminatedNCT00424294Phase 2Results posted
• Treatment of Hypovitaminosis D in Rheumatoid ArthritisCompletedNCT00423358Not applicableResults posted
• A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA)TerminatedNCT00422942Phase 2Results posted
• A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)CompletedNCT00422383Phase 3Results posted
• Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific RegionCompletedNCT00422227Phase 4Results posted
• Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid ArthritisCompletedNCT00420927Phase 4Results posted
• A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00420199Phase 3Results posted
• Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RACompletedNCT00418717Phase 3Results posted
• Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550CompletedNCT00414661Results posted
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisCompletedNCT00413699Phase 3Results posted
• Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid ArthritisCompletedNCT00413660Phase 2Results posted
• A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT00409838Phase 3Results posted
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)TerminatedNCT00406419Phase 3Results posted
• Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate TherapyCompletedNCT00405275Not applicableResults posted
• Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)TerminatedNCT00396812Phase 1/2Results posted
• Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)TerminatedNCT00394589Phase 3Results posted
• An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid ArthritisCompletedNCT00383188Phase 2Results posted
• A Safety and Pharmacokinetics Study in Participants With Rheumatoid ArthritisCompletedNCT00380744Phase 1/2Results posted
• Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving MethotrexateCompletedNCT00369928Phase 2Results posted
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid ArthritisCompletedNCT00361634Phase 1Results posted
• A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00361335Phase 3Results posted
• Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical TrialsCompletedNCT00357903Phase 3Results posted
• Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012CompletedNCT00356590Phase 3Results posted
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenCompletedNCT00346216Phase 4Results posted
• A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid ArthritisCompletedNCT00308282Phase 2Results posted
• Lovastatin for the Treatment of Mildly Active Rheumatoid ArthritisTerminatedNCT00302952Phase 2Results posted
• A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)CompletedNCT00299546Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid ArthritisCompletedNCT00299130Phase 3Results posted
• A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid ArthritisCompletedNCT00299104Phase 3Results posted
• Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid ArthritisTerminatedNCT00298272Phase 2Results posted
• Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty StudyCompletedNCT00289133Not applicableResults posted
• Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKACompletedNCT00289107Not applicableResults posted
• Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKACompletedNCT00289094Not applicableResults posted
• Rheumatoid Arthritis:Tolerance Induction by Mixed ChimerismTerminatedNCT00282412Phase 1Results posted
• A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background MethotrexateCompletedNCT00282308Phase 2Results posted
• Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis PatientsCompletedNCT00280917Phase 2Results posted
• Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisTerminatedNCT00273858Results posted
• A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background MethotrexateCompletedNCT00266227Phase 3Results posted
• An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00264550Phase 3Results posted
• A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naiveCompletedNCT00264537Phase 3Results posted
• Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)CompletedNCT00264147Phase 2Results posted
• Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)CompletedNCT00259610Phase 4Results posted
• Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)CompletedNCT00254293Phase 1/2Results posted
• A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving MethotrexateCompletedNCT00243412Phase 2Results posted
• Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235872Phase 3Results posted
• Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235833Phase 2Results posted
• Post-marketing Observational Study in Subjects With Rheumatoid ArthritisCompletedNCT00234884Results posted
• An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid ArthritisCompletedNCT00207714Phase 2Results posted
• Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.CompletedNCT00195702Phase 3Results posted
• Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisCompletedNCT00195663Phase 3Results posted
• Long Term Open Label Continuation StudyCompletedNCT00195650Phase 3Results posted
• Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid ArthritisCompletedNCT00195494Phase 4Results posted
• A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsACompletedNCT00195403Results posted
• Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In LuxemburgCompletedNCT00195338Results posted
• A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00175877Phase 3Results posted
• Abatacept With Methotrexate- Phase IIBCompletedNCT00162266Phase 2Results posted
• Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid ArthritisCompletedNCT00160693Phase 3Results posted
• A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160641Phase 3Results posted
• Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)CompletedNCT00147966Phase 2Results posted
• Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 WeeksCompletedNCT00147498Phase 2Results posted
• Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid ArthritisCompletedNCT00146640Phase 3Results posted
• Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With ArthritisCompletedNCT00141102Phase 4Results posted
• A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)CompletedNCT00132769Phase 2Results posted
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF TherapyCompletedNCT00124982Phase 3Results posted
• Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult PatientsCompletedNCT00124449Phase 2Results posted
• Remission and Joint Damage Progression in Early Rheumatoid ArthritisCompletedNCT00122382Phase 3Results posted
• A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)CompletedNCT00106535Phase 3Results posted
• Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid ArthritisCompletedNCT00095498Phase 2Results posted
• BMS-188667 in Children and Adolescents With Juvenile Rheumatoid ArthritisCompletedNCT00095173Phase 3Results posted
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid ArthritisCompletedNCT00095147Phase 3Results posted
• Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving MethotrexateTerminatedNCT00083759Phase 2Results posted
• Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid ArthritisTerminatedNCT00078806Phase 3Results posted
• A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00071812Phase 2Results posted
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid ArthritisCompletedNCT00048932Phase 3Results posted
• Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.CompletedNCT00048581Phase 3Results posted
• A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00048568Phase 3Results posted
• Experiences and Care Pathways Shared on Social Media Regarding 5 Conditions Causing Chronic PainCompletedNCT07871578
• Effects of Nonsurgical Periodontal Treatment on GCF Calprotectin and IL-10 in Rheumatoid ArthritisCompletedNCT07844564Not applicable
• Prospective Analysis of Blood Flow Restriction Training in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Compared to Conventional Strength TrainingCompletedNCT07772687Not applicable
• Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic StudyCompletedNCT07740200
• Impact of Optimised Protein Intake on Household Work Limitations and Disability in Rheumatoid ArthritisCompletedNCT07737119Not applicable
• A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance Along With Pharmaceutical and Non-pharmaceutical Therapy in the Early Rheumatoid ArthritisCompletedNCT07726355Phase 2/3
• Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid ArthritisCompletedNCT07715045Phase 2
• Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed ConditionsActive, not recruitingNCT07675226Phase 1
• Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individual Suffering From Rheumatoid ArthritisCompletedNCT07646470Not applicable
• Is a Standard Hand Rehabilitation Program Sufficient in Rheumatoid Arthritis Patients With Central SensitizationActive, not recruitingNCT07598240Not applicable
• Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint DiseaseCompletedNCT07580092
• A Study of BEN301 Injection in theTreatment of Autoimmune DiseasesSuspendedNCT07527936Early Phase 1
• Association of Pain With Body Image and Psychological Resilience in Rheumatoid Arthritis and FibromyalgiaCompletedNCT07446504
• Core Endurance, Finger Grip Strength, Fatigue, and Hand Function in Patients With Rheumatoid ArthritisCompletedNCT07360496
• Methotrexate Therapy and High-Resolution CT Chest and Spirometry Test Findings in Patients With Rheumatoid Arthritis.CompletedNCT07360340
• The Effect of Cold Application in Patients With Rheumatoid ArthritisCompletedNCT07359326Not applicable
• EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid ArthritisCompletedNCT07349420Phase 1/2
• Bone Density Change in Postmenopausal Rheumatoid ArthritisCompletedNCT07336693
• Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.CompletedNCT07335952Phase 2
• An Open-label Study of GC012F in Rheumatoid Arthritis.WithdrawnNCT07315503Early Phase 1
• Probiotics in Adults With Rheumatoid ArthritisActive, not recruitingNCT07304505Not applicable
• Effect of Siwan Sand Therapy on Pulmonary Functions of Rheumatoid Arthritis PatientsCompletedNCT07287696Not applicable
• Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease ActivityCompletedNCT07277491

← Arthritis, Rheumatoid overview